Imatinib mesylate induced skin hypopigmentation.
作者信息
Talwar V, Doval D C, Bhatia Komal
出版信息
J Assoc Physicians India. 2007 Jul;55:527.
PMID:17907508
Abstract
摘要
相似文献
1
Imatinib mesylate induced skin hypopigmentation.甲磺酸伊马替尼引起皮肤色素减退。
J Assoc Physicians India. 2007 Jul;55:527.
2
Imatinib mesylate causes hypopigmentation in the skin.甲磺酸伊马替尼可导致皮肤色素减退。
Cancer. 2004 Jun 1;100(11):2486-7; author reply 2487-8. doi: 10.1002/cncr.20267.
3
Imatinib mesylate causes hypopigmentation in the skin.甲磺酸伊马替尼可导致皮肤色素减退。
Cancer. 2003 Dec 1;98(11):2483-7. doi: 10.1002/cncr.11812.
4
Imatinib-related bone marrow aplasia after complete cytogenetic response in chronic myeloid leukemia.慢性髓性白血病完全细胞遗传学缓解后与伊马替尼相关的骨髓再生障碍
J Coll Physicians Surg Pak. 2008 Mar;18(3):176-8.
5
Imatinib and pregnancy.伊马替尼与妊娠
J Clin Oncol. 2006 Aug 10;24(23):3812-3; author reply 3813. doi: 10.1200/JCO.2006.06.9310.
6
Vitiligo-like lesions and diffuse lightening of the skin in a pediatric patient treated with imatinib mesylate: a noninvasive colorimetric assessment.接受甲磺酸伊马替尼治疗的儿科患者出现白癜风样皮损和皮肤弥漫性变浅：一项无创比色评估
Pediatr Dermatol. 2006 Mar-Apr;23(2):175-8. doi: 10.1111/j.1525-1470.2006.00208.x.
7
Tumour lysis syndrome with acute renal failure during imatinib therapy.伊马替尼治疗期间出现肿瘤溶解综合征伴急性肾衰竭。
Leuk Res. 2007 Apr;31(4):573-4. doi: 10.1016/j.leukres.2006.05.005. Epub 2006 Jun 16.
8
Partial fanconi syndrome induced by imatinib therapy: a novel cause of urinary phosphate loss.伊马替尼治疗引起的部分范科尼综合征：尿磷丢失的新原因。
Am J Kidney Dis. 2008 Feb;51(2):298-301. doi: 10.1053/j.ajkd.2007.10.039.
9
Primary ovarian insufficiency associated with imatinib therapy.与伊马替尼治疗相关的原发性卵巢功能不全。
N Engl J Med. 2008 Mar 6;358(10):1079-80. doi: 10.1056/NEJMc0707841.
10
Skin fragility and blistering with imatinib mesylate.甲磺酸伊马替尼所致皮肤脆性增加及水疱形成
J Eur Acad Dermatol Venereol. 2010 Apr;24(4):496-8. doi: 10.1111/j.1468-3083.2009.03456.x. Epub 2009 Nov 18.
Zotero 插件